These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 24644022)

  • 1. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.
    Chiche L; Jourde-Chiche N; Whalen E; Presnell S; Gersuk V; Dang K; Anguiano E; Quinn C; Burtey S; Berland Y; Kaplanski G; Harle JR; Pascual V; Chaussabel D
    Arthritis Rheumatol; 2014 Jun; 66(6):1583-95. PubMed ID: 24644022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus.
    Seguier J; Jouve E; Bobot M; Whalen E; Dussol B; Gentile S; Burtey S; Halfon P; Retornaz F; Chaussabel D; Chiche L; Jourde-Chiche N
    Rheumatology (Oxford); 2020 Aug; 59(8):1975-1983. PubMed ID: 31776548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.
    Paradowska-Gorycka A; Wajda A; Stypinska B; Walczuk E; Rzeszotarska E; Walczyk M; Haladyj E; Romanowska-Prochnicka K; Felis-Giemza A; Lewandowska A; Olesińska M
    Clin Exp Immunol; 2021 Apr; 204(1):49-63. PubMed ID: 33336388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
    Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
    Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis.
    Jourde-Chiche N; Whalen E; Gondouin B; Speake C; Gersuk V; Dussol B; Burtey S; Pascual V; Chaussabel D; Chiche L
    Rheumatology (Oxford); 2017 Mar; 56(3):477-487. PubMed ID: 28031441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
    Lood C; Amisten S; Gullstrand B; Jönsen A; Allhorn M; Truedsson L; Sturfelt G; Erlinge D; Bengtsson AA
    Blood; 2010 Sep; 116(11):1951-7. PubMed ID: 20538795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.
    Lauwerys BR; Hachulla E; Spertini F; Lazaro E; Jorgensen C; Mariette X; Haelterman E; Grouard-Vogel G; Fanget B; Dhellin O; Vandepapelière P; Houssiau FA
    Arthritis Rheum; 2013 Feb; 65(2):447-56. PubMed ID: 23203821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
    Hua J; Kirou K; Lee C; Crow MK
    Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
    Front Immunol; 2018; 9():3085. PubMed ID: 30666255
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition.
    Seridi L; Cesaroni M; Orillion A; Schreiter J; Chevrier M; Marciniak S; Migone TS; Stohl W; Chatham WW; Furie RA; Benson J; Jordan J
    Lupus; 2021 Apr; 30(5):795-806. PubMed ID: 33626969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
    Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
    Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature.
    Shobha V; Mohan A; Malini AV; Chopra P; Karunanithi P; Subramani Thulasingam S; Selvam S; Deyati A; Srivastava R; Basavanthappa S; Lemos N; Sunitha SM; Mazumder Tagore D; Anand A; Pant S; Jayaswal V; Ramarao M; Dudhgaonkar S
    Lupus; 2021 Apr; 30(5):762-774. PubMed ID: 33497307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus.
    Lee HM; Mima T; Sugino H; Aoki C; Adachi Y; Yoshio-Hoshino N; Matsubara K; Nishimoto N
    Arthritis Res Ther; 2009; 11(1):R1. PubMed ID: 19121222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
    Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
    PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
    Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
    Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.
    Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Baumgrass R; Stuhlmüller B; Maslinski W; Hiepe F; Burmester GR; Radbruch A; Häupl T; Grützkau A
    J Mol Med (Berl); 2012 Nov; 90(11):1295-309. PubMed ID: 22610275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
    Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
    Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.